We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.52 | -13.2992327366 | 3.91 | 4.2684 | 3.195 | 411808 | 3.86613213 | CS |
4 | 1.31 | 62.9807692308 | 2.08 | 4.2684 | 2.0625 | 294844 | 3.4272507 | CS |
12 | 1.65 | 94.8275862069 | 1.74 | 4.2684 | 1.59 | 142630 | 2.93440725 | CS |
26 | 1.3 | 62.2009569378 | 2.09 | 4.2684 | 1.555 | 98823 | 2.57231679 | CS |
52 | 1.4 | 70.351758794 | 1.99 | 4.2684 | 1.28 | 77405 | 2.24788272 | CS |
156 | 1.09 | 47.3913043478 | 2.3 | 5.7 | 1.02 | 370800 | 3.2215922 | CS |
260 | -0.97 | -22.247706422 | 4.36 | 5.7 | 1.02 | 401485 | 3.03890798 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions